{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T08:20:08Z","timestamp":1783326008488,"version":"3.54.6"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["PID2022-142086OB-I00"],"award-info":[{"award-number":["PID2022-142086OB-I00"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PT20\/0045"],"award-info":[{"award-number":["PT20\/0045"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PMPTA22\/00113"],"award-info":[{"award-number":["PMPTA22\/00113"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI21\/01110"],"award-info":[{"award-number":["PI21\/01110"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades,Spain","award":["RTC2019-07227-1"],"award-info":[{"award-number":["RTC2019-07227-1"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Biomed Sci"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pancreatic ductal adenocarcinoma (PDAC) remains one of the deadliest cancers due to late diagnosis, early metastasis and resistance to therapy. Cancer stem cells (CSCs) have been implicated in PDAC aggressiveness and treatment failure. MAP kinase-interacting kinase 1 (MNK1) is overexpressed in PDAC and plays a critical role in tumor progression and CSC maintenance. Here, we show the potential of apMNKQ2, a DNA aptamer targeting MNK1, to therapeutically target CSCs and reduce PDAC tumor burden in patient-derived xenografts (PDXs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>PDX cell lines and in vivo mouse models were used to assess the effects of apMNKQ2 on cell viability, apoptosis, cell cycle progression, migration, epithelial-to-mesenchymal transition (EMT) and CSC properties. Functional CSC targeting was validated through clonogenic and self-renewal assays as well as extreme limiting dilution analysis. Systemic administration of free apMNKQ2 was tested for biodistribution, pharmacokinetics, toxicity, and antitumor efficacy at escalating doses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>apMNKQ2 downregulated MNK1 and anti-apoptotic proteins (MCL1, XIAP), impaired cell proliferation, induced apoptosis, and disrupted cell cycle progression in PDX PDAC cells. Importantly, apMNKQ2 also inhibited migration, mesenchymal properties and angiogenesis in vitro, and lung colonization in vivo. Notably, apMNKQ2 strongly targeted PDAC CSCs, reducing CD24, CD133, CXCR4 and ALDH expression, clonogenicity and in vivo tumor initiation over 600-fold. Free apMNKQ2 (without transfection agents) entered PDAC cells efficiently, retaining anti-CSC activity. Systemic delivery of free apMNKQ2 accumulated in tumors, was well tolerated up to 400\u00a0mg\/kg and showed no toxicity. Importantly, 10\u00a0mg\/kg of apMNKQ2 produced strong antitumor effects in PDX models. Increasing the dose 20-fold enhanced tumor uptake but not efficacy, suggesting a therapeutic plateau at 10\u00a0mg\/kg.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>MNK1 plays a central role in PDAC progression and CSC maintenance. apMNKQ2 is a potent anti-MNK1 DNA aptamer with robust preclinical activity, including CSC-targeting and anti-invasive effects. Its low toxicity, systemic bioavailability, and efficacy at low doses support further development as a novel therapeutic strategy for PDAC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12929-026-01275-6","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T06:37:35Z","timestamp":1783319855000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Aptamer-based inhibition of MNK1 reduces pancreatic ductal adenocarcinoma growth by targeting cancer stem cells"],"prefix":"10.1186","volume":"33","author":[{"given":"Alberto","family":"P\u00e9rez-Ruiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Ruiz-Ca\u00f1as","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Batres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Ferreras-Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celia","family":"Pinto-D\u00edez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balbino","family":"Yag\u00fce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Isabel","family":"P\u00e9rez-Morgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Sacrist\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Ruz-Caracuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia Cama\u00f1o","family":"P\u00e1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Sanchez-Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00edctor M.","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Alcal\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Elena","family":"Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4829-7651","authenticated-orcid":false,"suffix":"Jr.","given":"Bruno","family":"Sainz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"key":"1275_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27020383","author":"MM Aljohani","year":"2022","unstructured":"Aljohani MM, Cialla-May D, Popp J, Chinnappan R, Al-Kattan K, Zourob M. Aptamers: potential diagnostic and therapeutic agents for blood diseases. Molecules. 2022. https:\/\/doi.org\/10.3390\/molecules27020383.","journal-title":"Molecules"},{"issue":"7592","key":"1275_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature16965","volume":"531","author":"P Bailey","year":"2016","unstructured":"Bailey P, Chang DK, Nones K, Johns AL, Patch AM, Gingras MC, et al. Genomic analyses identify molecular subtypes of pancreatic cancer. Nature. 2016;531(7592):47\u201352.","journal-title":"Nature"},{"issue":"3","key":"1275_CR3","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.yexmp.2009.01.004","volume":"86","author":"PJ Bates","year":"2009","unstructured":"Bates PJ, Laber DA, Miller DM, Thomas SD, Trent JO. Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer. Exp Mol Pathol. 2009;86(3):151\u201364.","journal-title":"Exp Mol Pathol"},{"issue":"10","key":"1275_CR4","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1158\/1541-7786.MCR-16-0172","volume":"14","author":"JB Bell","year":"2016","unstructured":"Bell JB, Eckerdt FD, Alley K, Magnusson LP, Hussain H, Bi Y, et al. MNK inhibition disrupts mesenchymal glioma stem cells and prolongs survival in a mouse model of glioblastoma. Mol Cancer Res. 2016;14(10):984\u201393.","journal-title":"Mol Cancer Res"},{"key":"1275_CR5","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.biochi.2015.03.023","volume":"113","author":"CM Berger","year":"2015","unstructured":"Berger CM, Gaume X, Bouvet P. The roles of nucleolin subcellular localization in cancer. Biochimie. 2015;113:78\u201385.","journal-title":"Biochimie"},{"key":"1275_CR6","doi-asserted-by":"crossref","unstructured":"Buxade M., Morrice N., Krebs D.L. and Proud C.G 2008 The PSF.p54nrb complex is a novel Mnk substrate that binds the mRNA for tumor necrosis factor alpha. J Biol Chem 283 1 57\u201365","DOI":"10.1074\/jbc.M705286200"},{"issue":"2","key":"1275_CR7","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.immuni.2005.06.009","volume":"23","author":"M Buxade","year":"2005","unstructured":"Buxade M, Parra JL, Rousseau S, Shpiro N, Marquez R, Morrice N, et al. The Mnks are novel components in the control of TNF alpha biosynthesis and phosphorylate and regulate hnRNP A1. Immunity. 2005;23(2):177\u201389.","journal-title":"Immunity"},{"key":"1275_CR8","doi-asserted-by":"publisher","first-page":"5359","DOI":"10.2741\/3086","volume":"13","author":"M Buxade","year":"2008","unstructured":"Buxade M, Parra-Palau JL, Proud CG. The Mnks: MAP kinase-interacting kinases (MAP kinase signal-integrating kinases). Front Biosci. 2008;13:5359\u201373.","journal-title":"Front Biosci"},{"key":"1275_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15041273","author":"R Carrion-Marchante","year":"2023","unstructured":"Carrion-Marchante R, Pinto-Diez C, Klett-Mingo JI, Palacios E, Barragan-Usero M, Perez-Morgado MI, et al. An aptamer against MNK1 for non-small cell lung cancer treatment. Pharmaceutics. 2023. https:\/\/doi.org\/10.3390\/pharmaceutics15041273.","journal-title":"Pharmaceutics"},{"issue":"6","key":"1275_CR10","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1136\/gutjnl-2013-306068","volume":"64","author":"J Cendrowski","year":"2015","unstructured":"Cendrowski J, Lobo VJ, Sendler M, Salas A, Kuhn JP, Molero X, et al. Mnk1 is a novel acinar cell-specific kinase required for exocrine pancreatic secretion and response to pancreatitis in mice. Gut. 2015;64(6):937\u201347.","journal-title":"Gut"},{"issue":"6","key":"1275_CR11","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/aps.2013.27","volume":"34","author":"K Chen","year":"2013","unstructured":"Chen K, Huang YH, Chen JL. Understanding and targeting cancer stem cells: therapeutic implications and challenges. Acta Pharmacol Sin. 2013;34(6):732\u201340.","journal-title":"Acta Pharmacol Sin"},{"issue":"4","key":"1275_CR12","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41575-019-0109-y","volume":"16","author":"EA Collisson","year":"2019","unstructured":"Collisson EA, Bailey P, Chang DK, Biankin AV. Molecular subtypes of pancreatic cancer. Nat Rev Gastroenterol Hepatol. 2019;16(4):207\u201320.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"1275_CR13","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/nm.2344","volume":"17","author":"EA Collisson","year":"2011","unstructured":"Collisson EA, Sadanandam A, Olson P, Gibb WJ, Truitt M, Gu S, et al. Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy. Nat Med. 2011;17(4):500\u20133.","journal-title":"Nat Med"},{"issue":"27","key":"1275_CR14","doi-asserted-by":"publisher","first-page":"5469","DOI":"10.1038\/s41388-019-0803-9","volume":"38","author":"G D'Errico","year":"2019","unstructured":"D\u2019Errico G, Alonso-Nocelo M, Vallespinos M, Hermann PC, Alcala S, Garcia CP, et al. Tumor-associated macrophage-secreted 14-3-3zeta signals via AXL to promote pancreatic cancer chemoresistance. Oncogene. 2019;38(27):5469\u201385.","journal-title":"Oncogene"},{"issue":"5","key":"1275_CR15","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1128\/MCB.26.5.1898-1907.2006","volume":"26","author":"J DaSilva","year":"2006","unstructured":"DaSilva J, Xu L, Kim HJ, Miller WT, Bar-Sagi D. Regulation of sprouty stability by Mnk1-dependent phosphorylation. Mol Cell Biol. 2006;26(5):1898\u2013907.","journal-title":"Mol Cell Biol"},{"key":"1275_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2025.02.045","author":"V DeFranciscis","year":"2025","unstructured":"DeFranciscis V, Amabile G, Kortylewski M. Clinical applications of oligonucleotides for cancer therapy. Mol Ther. 2025. https:\/\/doi.org\/10.1016\/j.ymthe.2025.02.045.","journal-title":"Mol Ther"},{"issue":"8","key":"1275_CR17","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1158\/1535-7163.MCT-19-1166","volume":"19","author":"S Dimitrov-Markov","year":"2020","unstructured":"Dimitrov-Markov S, Perales-Paton J, Bockorny B, Dopazo A, Munoz M, Banos N, et al. Discovery of new targets to control metastasis in pancreatic cancer by single-cell transcriptomics analysis of circulating tumor cells. Mol Cancer Ther. 2020;19(8):1751\u201360.","journal-title":"Mol Cancer Ther"},{"issue":"6287","key":"1275_CR18","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/346818a0","volume":"346","author":"AD Ellington","year":"1990","unstructured":"Ellington AD, Szostak JW. In vitro selection of RNA molecules that bind specific ligands. Nature. 1990;346(6287):818\u201322.","journal-title":"Nature"},{"issue":"7","key":"1275_CR19","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1158\/0008-5472.CAN-17-1667","volume":"78","author":"MK Evans","year":"2018","unstructured":"Evans MK, Brown MC, Geradts J, Bao X, Robinson TJ, Jolly MK, et al. XIAP Regulation by MNK Links MAPK and NFkappaB signaling to determine an aggressive breast cancer phenotype. Cancer Res. 2018;78(7):1726\u201338.","journal-title":"Cancer Res"},{"issue":"1","key":"1275_CR20","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1146\/annurev-cancerbio-060624-044323","volume":"9","author":"LP Ferguson","year":"2025","unstructured":"Ferguson LP, Tuveson DA. Road Map to Defeat Pancreatic Cancer. Annual Review of Cancer Biol. 2025;9(1):20.","journal-title":"Annual Review of Cancer Biol"},{"issue":"8","key":"1275_CR21","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1016\/j.ymthe.2018.05.019","volume":"26","author":"G Fernandez","year":"2018","unstructured":"Fernandez G, Moraga A, Cuartero MI, Garcia-Culebras A, Pena-Martinez C, Pradillo JM, et al. TLR4-binding DNA aptamers show a protective effect against acute stroke in animal models. Mol Ther. 2018;26(8):2047\u201359.","journal-title":"Mol Ther"},{"issue":"21","key":"1275_CR22","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1056\/NEJM197111182852108","volume":"285","author":"J Folkman","year":"1971","unstructured":"Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med. 1971;285(21):1182\u20136.","journal-title":"N Engl J Med"},{"key":"1275_CR23","first-page":"3040","volume":"55","author":"RA Francescone 3rd","year":"2011","unstructured":"Francescone RA 3rd, Faibish M, Shao R. A Matrigel-based tube formation assay to assess the vasculogenic activity of tumor cells. J Vis Exp. 2011;55:3040.","journal-title":"J Vis Exp"},{"issue":"11","key":"1275_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100815","volume":"3","author":"KJ Frank","year":"2022","unstructured":"Frank KJ, Mulero-Sanchez A, Berninger A, Ruiz-Canas L, Bosma A, Gorgulu K, et al. Extensive preclinical validation of combined RMC-4550 and LY3214996 supports clinical investigation for KRAS mutant pancreatic cancer. Cell Rep Med. 2022;3(11):100815.","journal-title":"Cell Rep Med"},{"issue":"8","key":"1275_CR25","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1093\/emboj\/16.8.1921","volume":"16","author":"R Fukunaga","year":"1997","unstructured":"Fukunaga R, Hunter T. MNK1, a new MAP kinase-activated protein kinase, isolated by a novel expression screening method for identifying protein kinase substrates. EMBO J. 1997;16(8):1921\u201333.","journal-title":"EMBO J"},{"issue":"1","key":"1275_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2015.50","volume":"5","author":"EM Garcia-Recio","year":"2016","unstructured":"Garcia-Recio EM, Pinto-Diez C, Perez-Morgado MI, Garcia-Hernandez M, Fernandez G, Martin ME, et al. Characterization of MNK1b DNA Aptamers That Inhibit Proliferation in MDA-MB231 Breast Cancer Cells. Mol Ther Nucleic Acids. 2016;5(1):e275.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"27","key":"1275_CR27","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1056\/NEJMoa042760","volume":"351","author":"ES Gragoudas","year":"2004","unstructured":"Gragoudas ES, Adamis AP, Cunningham ET Jr., Feinsod M, Guyer DR, Group V.I.S.i.O.N.C.T. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med. 2004;351(27):2805\u201316.","journal-title":"N Engl J Med"},{"issue":"6","key":"1275_CR28","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1158\/0008-5472.CAN-10-3112","volume":"71","author":"M Grzmil","year":"2011","unstructured":"Grzmil M, Morin P Jr, Lino MM, Merlo A, Frank S, Wang Y, et al. MAP kinase-interacting kinase 1 regulates SMAD2-dependent TGF-beta signaling pathway in human glioblastoma. Cancer Res. 2011;71(6):2392\u2013402.","journal-title":"Cancer Res"},{"issue":"7","key":"1275_CR29","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1158\/0008-5472.CAN-18-1602","volume":"79","author":"Q Guo","year":"2019","unstructured":"Guo Q, Li VZ, Nichol JN, Huang F, Yang W, Preston SEJ, et al. MNK1\/NODAL signaling promotes invasive progression of breast ductal carcinoma in situ. Cancer Res. 2019;79(7):1646\u201357.","journal-title":"Cancer Res"},{"issue":"1","key":"1275_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-10397-9","volume":"7","author":"Z Guo","year":"2017","unstructured":"Guo Z, Peng G, Li E, Xi S, Zhang Y, Li Y, et al. MAP kinase-interacting serine\/threonine kinase 2 promotes proliferation, metastasis, and predicts poor prognosis in non-small cell lung cancer. Sci Rep. 2017;7(1):10612.","journal-title":"Sci Rep"},{"issue":"48","key":"1275_CR31","doi-asserted-by":"publisher","first-page":"37542","DOI":"10.1074\/jbc.M003395200","volume":"275","author":"Y Hefner","year":"2000","unstructured":"Hefner Y, Borsch-Haubold AG, Murakami M, Wilde JI, Pasquet S, Schieltz D, et al. Serine 727 phosphorylation and activation of cytosolic phospholipase A2 by MNK1-related protein kinases. J Biol Chem. 2000;275(48):37542\u201351.","journal-title":"J Biol Chem"},{"issue":"3","key":"1275_CR32","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.stem.2007.06.002","volume":"1","author":"PC Hermann","year":"2007","unstructured":"Hermann PC, Huber SL, Herrler T, Aicher A, Ellwart JW, Guba M, et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell. 2007;1(3):313\u201323.","journal-title":"Cell Stem Cell"},{"key":"1275_CR33","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.semcancer.2018.08.007","volume":"53","author":"PC Hermann","year":"2018","unstructured":"Hermann PC, Sainz B Jr. Pancreatic cancer stem cells: a state or an entity? Semin Cancer Biol. 2018;53:223\u201331.","journal-title":"Semin Cancer Biol"},{"issue":"8","key":"1275_CR34","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1001\/jamaneurol.2023.1660","volume":"80","author":"M Hernandez-Jimenez","year":"2023","unstructured":"Hernandez-Jimenez M, Abad-Santos F, Cotgreave I, Gallego J, Jilma B, Flores A, et al. Safety and Efficacy of ApTOLL in Patients With Ischemic Stroke Undergoing Endovascular Treatment: A Phase 1\/2 Randomized Clinical Trial. JAMA Neurol. 2023;80(8):779\u201388.","journal-title":"JAMA Neurol"},{"key":"1275_CR35","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.omtn.2022.03.005","volume":"28","author":"M Hernandez-Jimenez","year":"2022","unstructured":"Hernandez-Jimenez M, Martin-Vilchez S, Ochoa D, Mejia-Abril G, Roman M, Camargo-Mamani P, et al. First-in-human phase I clinical trial of a TLR4-binding DNA aptamer, ApTOLL: safety and pharmacokinetics in healthy volunteers. Mol Ther Nucleic Acids. 2022;28:124\u201335.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"7","key":"1275_CR36","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1182\/blood-2013-03-493924","volume":"123","author":"J Hoellenriegel","year":"2014","unstructured":"Hoellenriegel J, Zboralski D, Maasch C, Rosin NY, Wierda WG, Keating MJ, et al. The Spiegelmer NOX-A12, a novel CXCL12 inhibitor, interferes with chronic lymphocytic leukemia cell motility and causes chemosensitization. Blood. 2014;123(7):1032\u20139.","journal-title":"Blood"},{"issue":"15","key":"1275_CR37","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1007\/s40265-023-01948-8","volume":"83","author":"C Kang","year":"2023","unstructured":"Kang C. Avacincaptad pegol: first approval. Drugs. 2023;83(15):1447\u201353.","journal-title":"Drugs"},{"issue":"15","key":"1275_CR38","doi-asserted-by":"publisher","first-page":"4016","DOI":"10.7150\/thno.25958","volume":"8","author":"H Kaur","year":"2018","unstructured":"Kaur H, Bruno JG, Kumar A, Sharma TK. Aptamers in the therapeutics and diagnostics pipelines. Theranostics. 2018;8(15):4016\u201332.","journal-title":"Theranostics"},{"issue":"25","key":"1275_CR39","doi-asserted-by":"publisher","first-page":"E2298","DOI":"10.1073\/pnas.1301838110","volume":"110","author":"S Lim","year":"2013","unstructured":"Lim S, Saw TY, Zhang M, Janes MR, Nacro K, Hill J, et al. Targeting of the MNK-eIF4E axis in blast crisis chronic myeloid leukemia inhibits leukemia stem cell function. Proc Natl Acad Sci U S A. 2013;110(25):E2298-2307.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1275_CR40","doi-asserted-by":"publisher","DOI":"10.1002\/cpph.43","volume":"83","author":"JR Mathiasen","year":"2018","unstructured":"Mathiasen JR, Moser VC. The Irwin test and functional observational battery (FOB) for assessing the effects of compounds on behavior, physiology, and safety pharmacology in rodents. Curr Protoc Pharmacol. 2018;83(1):e43.","journal-title":"Curr Protoc Pharmacol"},{"issue":"10","key":"1275_CR41","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1038\/ng.3398","volume":"47","author":"RA Moffitt","year":"2015","unstructured":"Moffitt RA, Marayati R, Flate EL, Volmar KE, Loeza SG, Hoadley KA, et al. Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma. Nat Genet. 2015;47(10):1168\u201378.","journal-title":"Nat Genet"},{"issue":"25","key":"1275_CR42","doi-asserted-by":"publisher","first-page":"4181","DOI":"10.2174\/0929867326666191001125101","volume":"27","author":"SM Nimjee","year":"2020","unstructured":"Nimjee SM, Sullenger BA. Therapeutic aptamers: evolving to find their clinical niche. Curr Med Chem. 2020;27(25):4181\u201393.","journal-title":"Curr Med Chem"},{"issue":"4","key":"1275_CR43","doi-asserted-by":"publisher","first-page":"295","DOI":"10.4161\/cbt.23622","volume":"14","author":"X Ning","year":"2013","unstructured":"Ning X, Shu J, Du Y, Ben Q, Li Z. Therapeutic strategies targeting cancer stem cells. Cancer Biol Ther. 2013;14(4):295\u2013303.","journal-title":"Cancer Biol Ther"},{"key":"1275_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21082967","author":"C Pinto-Diez","year":"2020","unstructured":"Pinto-Diez C, Ferreras-Martin R, Carrion-Marchante R, Gonzalez VM, Martin ME. Deeping in the role of the MAP-kinases interacting kinases (MNKs) in cancer. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21082967.","journal-title":"Int J Mol Sci"},{"key":"1275_CR45","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.omtn.2022.11.009","volume":"30","author":"C Pinto-Diez","year":"2022","unstructured":"Pinto-Diez C, Ferreras-Martin R, Carrion-Marchante R, Klett-Mingo JI, Garcia-Hernandez M, Perez-Morgado MI, et al. An optimized MNK1b aptamer, apMNKQ2, and its potential use as a therapeutic agent in breast cancer. Mol Ther Nucleic Acids. 2022;30:553\u201368.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"17","key":"1275_CR46","doi-asserted-by":"publisher","first-page":"13501","DOI":"10.18632\/oncotarget.24417","volume":"9","author":"C Pinto-Diez","year":"2018","unstructured":"Pinto-Diez C, Garcia-Recio EM, Perez-Morgado MI, Garcia-Hernandez M, Sanz-Criado L, Sacristan S, et al. Increased expression of MNK1b, the spliced isoform of MNK1, predicts poor prognosis and is associated with triple-negative breast cancer. Oncotarget. 2018;9(17):13501\u201316.","journal-title":"Oncotarget"},{"key":"1275_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21114055","author":"SA Prabhu","year":"2020","unstructured":"Prabhu SA, Moussa O, Miller WH Jr., Del Rincon SV. The MNK1\/2-eIF4E axis as a potential therapeutic target in melanoma. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21114055.","journal-title":"Int J Mol Sci"},{"issue":"37","key":"1275_CR48","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adi7673","volume":"10","author":"SEJ Preston","year":"2024","unstructured":"Preston SEJ, Dahabieh MS, Flores Gonzalez RE, Goncalves C, Richard VR, Leibovitch M, et al. Blocking tumor-intrinsic MNK1 kinase restricts metabolic adaptation and diminishes liver metastasis. Sci Adv. 2024;10(37):eadi7673.","journal-title":"Sci Adv"},{"issue":"5","key":"1275_CR49","doi-asserted-by":"publisher","first-page":"3195","DOI":"10.18632\/oncotarget.3084","volume":"6","author":"VP Ramamurthy","year":"2015","unstructured":"Ramamurthy VP, Ramalingam S, Gediya L, Kwegyir-Afful AK, Njar VC. Simultaneous targeting of androgen receptor (AR) and MAPK-interacting kinases (MNKs) by novel retinamides inhibits growth of human prostate cancer cell lines. Oncotarget. 2015;6(5):3195\u2013210.","journal-title":"Oncotarget"},{"issue":"1","key":"1275_CR50","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.stem.2018.11.017","volume":"24","author":"C Saygin","year":"2019","unstructured":"Saygin C, Matei D, Majeti R, Reizes O, Lathia JD. Targeting cancer stemness in the clinic: from hype to hope. Cell Stem Cell. 2019;24(1):25\u201340.","journal-title":"Cell Stem Cell"},{"issue":"4968","key":"1275_CR51","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1126\/science.2200121","volume":"249","author":"C Tuerk","year":"1990","unstructured":"Tuerk C, Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science. 1990;249(4968):505\u201310.","journal-title":"Science"},{"key":"1275_CR52","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.12659\/MSM.909012","volume":"24","author":"X Wang","year":"2018","unstructured":"Wang X, Wang Y, Zhang Q, Zhuang H, Chen B. MAP kinase-interacting kinase 1 promotes proliferation and invasion of hepatocellular carcinoma and is an unfavorable prognostic biomarker. Med Sci Monit. 2018;24:1759\u201367.","journal-title":"Med Sci Monit"},{"issue":"8","key":"1275_CR53","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1093\/emboj\/16.8.1909","volume":"16","author":"AJ Waskiewicz","year":"1909","unstructured":"Waskiewicz AJ, Flynn A, Proud CG, Cooper JA. Mitogen-activated protein kinases activate the serine\/threonine kinases Mnk1 and Mnk2. EMBO J. 1909;16(8):1909\u201320.","journal-title":"EMBO J"},{"issue":"24","key":"1275_CR54","doi-asserted-by":"publisher","first-page":"3232","DOI":"10.1101\/gad.1604407","volume":"21","author":"HG Wendel","year":"2007","unstructured":"Wendel HG, Silva RL, Malina A, Mills JR, Zhu H, Ueda T, et al. Dissecting eIF4E action in tumorigenesis. Genes Dev. 2007;21(24):3232\u20137.","journal-title":"Genes Dev"},{"issue":"7","key":"1275_CR55","doi-asserted-by":"publisher","first-page":"728","DOI":"10.4161\/cbt.10.7.12965","volume":"10","author":"MJ Wheater","year":"2010","unstructured":"Wheater MJ, Johnson PW, Blaydes JP. The role of MNK proteins and eIF4E phosphorylation in breast cancer cell proliferation and survival. Cancer Biol Ther. 2010;10(7):728\u201335.","journal-title":"Cancer Biol Ther"},{"key":"1275_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102655","volume":"53","author":"W Yao","year":"2020","unstructured":"Yao W, Maitra A, Ying H. Recent insights into the biology of pancreatic cancer. EBioMedicine. 2020;53:102655.","journal-title":"EBioMedicine"},{"issue":"3","key":"1275_CR57","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nrd.2016.199","volume":"16","author":"J Zhou","year":"2017","unstructured":"Zhou J, Rossi J. Aptamers as targeted therapeutics: current potential and challenges. Nat Rev Drug Discov. 2017;16(3):181\u2013202.","journal-title":"Nat Rev Drug Discov"}],"container-title":["Journal of Biomedical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12929-026-01275-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12929-026-01275-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12929-026-01275-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T08:03:58Z","timestamp":1783325038000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12929-026-01275-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1275"],"URL":"https:\/\/doi.org\/10.1186\/s12929-026-01275-6","relation":{},"ISSN":["1423-0127"],"issn-type":[{"value":"1423-0127","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,6]]},"assertion":[{"value":"16 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All in vivo procedures in mice were conducted in accordance with protocols approved by the Use Committee for Animal Care from the Universidad Aut\u00f3noma de Madrid (UAM) (Ref# CEI-25-587) and the Comunidad de Madrid (PROEX 294\/19, 205.23). Mice were housed according to institutional guidelines and all experimental procedures were performed in compliance with the institutional guidelines for the welfare of experimental animals and in accordance with the guidelines for Ethical Conduct in the Care and Use of Animals as stated in The International Guiding Principles for Biomedical Research involving Animals, developed by the Council for International Organizations of Medical Sciences (CIOMS). The human dataset from Bailey et al. is publicly available and was downloaded from [\n                      \n                      ].","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"We disclose the following patent application PCT\/EP2019\/083547 (12\/03\/2019) and patent registration EP24382947.0 (09\/03\/2024) related to the work presented in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"72"}}